Mette Kirstine Agger, Lundbeckfonden

Mette Kirstine Agger, as Managing Partner of Lundbeckfonden Ventures, invests in early-to-mid-stage biotechnology. See sector focus and contact routes.

About Mette Kirstine Agger

Mette Kirstine Agger, as Managing Partner of Lundbeckfonden Ventures, invests in early-to-mid-stage biotechnology, health tech, and pharmaceutical companies—particularly those in clinical development—with typical check sizes of €3–€10 million. Her portfolio includes notable life science firms such as Notify Therapeutics, AFYX Therapeutics, NMD Pharma, Tiburio (developing treatments for rare tumours), and Sanifit Therapeutics (acquired by Vifor Pharma). Agger’s distinctive thesis emphasizes advancing neuroscience discoveries and therapies for rare genetic diseases, requiring founders to demonstrate robust clinical or translational data and a clear path to significant medical impact.

Mette Kirstine Agger at a glance

Role
Managing Partner
Organization
Lundbeckfonden Ventures
Location
Copenhagen, Hovedstaden, Denmark
Investor type
Venture Capital
Focus areas
Biotechnology, Venture Capital, Health Care, Therapeutics, Pharmaceutical, Medical, Biopharma, Medical Device

Frequently asked about Mette Kirstine Agger

What does Mette Kirstine Agger invest in?
Mette Kirstine Agger at Lundbeckfonden Ventures (Copenhagen, Hovedstaden, Denmark) — sector focus: Biotechnology, Venture Capital, Health Care, Therapeutics, Pharmaceutical, Medical, Biopharma, Medical Device, Manufacturing, Life Science, Hospital, Early Sta….
How do I contact Mette Kirstine Agger?
Mette Kirstine Agger's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Mette Kirstine Agger based?
Mette Kirstine Agger is based in Copenhagen, Hovedstaden, Denmark.

Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Copenhagen.

Investors similar to Mette Kirstine Agger (20)

Browse related investor lists (1)

Compare Mette Kirstine Agger (8)

Investors like Mette Kirstine Agger · Full investor directory · Investor access · Company funding database

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades